Skip to main content
Figure 1 | Molecular Cancer

Figure 1

From: MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3

Figure 1

The levels of miR-223 and pre-miR-223 in platelets isolated from NSCLC patients or Lewis lung carcinoma mice. (A) The absolute levels of miR-223 in the platelet from healthy volunteers and NSCLC patients detected by qRT-PCR. (B) The relative levels of pre-miR-223 in the platelet from healthy volunteers and NSCLC patients detected by qRT-PCR. (C) The absolute levels of miR-223 in the platelet of Lewis lung carcinoma mice detected by qRT-PCR. (D) The relative levels of pre-miR-223 in the platelet of Lewis lung carcinoma mice detected by qRT-PCR. The levels of miR-223 and pre-miR-223 were assessed by qRT-PCR and normalized against blood volume. Results are presented as mean ± SEM of five independent experiments (*, P < 0.05, **, P < 0.01,***, P < 0.001).

Back to article page